MODAG GmbH
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on MODAG GmbH
Scrip
• By Alaric DeArment
Inhibikase Therapeutics, Inc. is back in the race to develop a drug to treat multiple system atrophy (MSA) now that the US Food and Drug Administration has lifted a full clinical hold on IkT-148009,
Scrip
• By Joseph Haas and Ayisha Sharma
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck Inks Platform Licensing Agreement
Scrip
• By Jessica Merrill
Teva Pharmaceutical Industries Ltd. 's neurology portfolio is showing renewed growth and the company is looking to build on that foundation with the addition of two new pipeline assets, in a deal anno